InvestSMART

Chrysos Corporation Limited (ASX:C79)

ALERT: Price-sensitive ASX Announcement for C79
Current share price for C79 : $7.060 0.61 (9.46%)+
Announcement
Release
11 Aug 2026 8:44AM
Price at Release
$6.450
Full Release
download
Summary
Chrysos Corporation Limited reported strong financial results for FY26, with total revenue reaching $88.1 million, a 33% increase from FY25. The company achieved an EBITDA of $27.2 million, marking a 68% rise from the previous year, attributable to higher utilisation and demand for its PhotonAssayTM technology. Chrysos expanded its global footprint by deploying units in key regions such as South America and Australia, and secured 24 new lease agreements during the year, increasing its contracted units to 87. The company also strengthened its financial position by refinancing its debt and securing a new $200 million syndicated facility, boosting its capacity for manufacturing and deployment. Looking ahead to FY27, Chrysos projects revenue between $108 million and $118 million, driven by continued adoption of PhotonAssayTM technology and expansion into non-gold commodities.
Key Points
  • Total revenue of $88.1 million, a 33% increase from FY25.
  • EBITDA rose by 68% to $27.2 million.
  • 24 new lease agreements signed in FY26.
  • Deployment of first unit to South America.
  • New $200 million syndicated debt facility secured.
  • Projected FY27 revenue between $108 million and $118 million.
  • PhotonAssay technology adoption and global expansion continued.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.